← All Signals

🏥 FDA: Agebox — Class II

healthcareactionableSource: FDA
97%Confidence
1Views
FDASource
2026-03-11Date

Summary

Recall of Agebox children's growth supplement due to undeclared ibutamoren (a SARMs-like substance) highlights significant regulatory and safety risks in the dietary supplement market. This illegal inclusion poses health risks and exposes the company to legal action.

Actionable: Immediately discontinue sale and use of Agebox iKids-Growth products and report adverse events to the FDA, as they contain an unapproved drug ingredient.

AI Confidence: 97%

Data Points

firmAgebox
classificationClass II
statusOngoing
distributionThe product was distributed nationwide in the U.S. Agebox sells its U.S. products through Agebox.com (using Shopify) and Amazon.com. All orders are shipped to customers by Agebox itself; other parties are not involved in the distribution of the physical product.
productAgebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 850065597027

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now